| Entry |
|
|---|
| Name |
Adenosine phosphate (USAN/INN);
Adenyl (TN) |
|---|
| Formula |
C10H14N5O7P
|
|---|
| Exact mass |
347.0631
|
|---|
| Mol weight |
347.2212
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Remark |
| Product (DG00243): | D00045<JP/US> D02300<JP> |
|
|---|
| Efficacy |
Supplement (nutrient) |
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C01 CARDIAC THERAPY
C01E OTHER CARDIAC PREPARATIONS
C01EB Other cardiac preparations
C01EB10 Adenosine
D02769 Adenosine phosphate (USAN/INN)
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Adenosine
ADORA
D02769 Adenosine phosphate (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 23
1 N4y N 27.1600 -15.6800
2 C8y C 28.2100 -16.4500
3 C1y C 25.8300 -16.1000
4 C8x C 27.5800 -14.2800
5 C8y C 29.4000 -15.5400
6 N5x N 28.3500 -17.8500
7 O2x O 24.7100 -15.2600
8 C1y C 25.4100 -17.3600
9 N5x N 29.0500 -14.2800
10 C8y C 30.6600 -16.1000
11 C8x C 29.6800 -18.4100
12 C1y C 23.5900 -16.0300
13 C1y C 24.0100 -17.3600
14 O1a O 26.1800 -18.4800
15 N5x N 30.8700 -17.5700
16 N1a N 31.7800 -15.2600
17 C1b C 22.2600 -15.6100
18 O1a O 23.5900 -18.6900
19 O2b O 21.2100 -16.5900
20 P1b P 19.8100 -16.5900
21 O1c O 18.4100 -16.5900
22 O1c O 19.8100 -17.9900
23 O1c O 19.8100 -15.1200
BOND 25
1 1 2 1
2 3 1 1 #Up
3 1 4 1
4 2 5 2
5 2 6 1
6 3 7 1
7 3 8 1
8 4 9 2
9 5 10 1
10 6 11 2
11 7 12 1
12 8 13 1
13 8 14 1 #Down
14 10 15 2
15 10 16 1
16 12 17 1 #Up
17 13 18 1 #Down
18 17 19 1
19 19 20 1
20 20 21 1
21 20 22 1
22 20 23 2
23 5 9 1
24 11 15 1
25 12 13 1
|
|---|
